Literature DB >> 20011162

Hepatic resection in Canada: rates and geographic variation.

Ryan J McColl1, Balpreet Brar, William A Ghali, Elijah Dixon.   

Abstract

BACKGROUND: Liver resection (LR) is the only curative therapy for hepatic malignancy. Despite this, the rates of LR across Canada are unknown. We sought to determine the rate and regional variation of LR in Canada, its provinces and census divisions for the period 1995-2004.
METHODS: We obtained discharge data for 1995-2004 from all provinces but Quebec from the Canadian Institute for Health Information, and we searched for LR by residential site. Then we calculated rates and variations in rates.
RESULTS: The national age- and sex-adjusted rate of LR per 100,000 people aged 18 years and older increased from 3.22 in 1995 to 5.86 in 2004. There was a high degree of variation across provinces and census divisions.
CONCLUSION: Liver resection volumes are increasing in Canada. Significant regional variation exists for LR in Canada, likely reflecting a variety of important supply-demand issues.

Entities:  

Mesh:

Year:  2009        PMID: 20011162      PMCID: PMC2792413     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  24 in total

1.  National trends in the use and outcomes of hepatic resection.

Authors:  Justin B Dimick; Reid M Wainess; John A Cowan; Gilbert R Upchurch; James A Knol; Lisa M Colletti
Journal:  J Am Coll Surg       Date:  2004-07       Impact factor: 6.113

2.  Controlling variation in health care: a consultation from Walter Shewhart.

Authors:  D M Berwick
Journal:  Med Care       Date:  1991-12       Impact factor: 2.983

3.  Variations in the use of medical and surgical services by the Medicare population.

Authors:  M R Chassin; R H Brook; R E Park; J Keesey; A Fink; J Kosecoff; K Kahn; N Merrick; D H Solomon
Journal:  N Engl J Med       Date:  1986-01-30       Impact factor: 91.245

4.  Solid liver tumors.

Authors:  J H Foster; M M Berman
Journal:  Major Probl Clin Surg       Date:  1977

5.  Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection.

Authors:  J Belghiti; K Hiramatsu; S Benoist; P Massault; A Sauvanet; O Farges
Journal:  J Am Coll Surg       Date:  2000-07       Impact factor: 6.113

6.  Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database.

Authors:  Justin B Dimick; John A Cowan; James A Knol; Gilbert R Upchurch
Journal:  Arch Surg       Date:  2003-02

7.  Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.

Authors:  T J Gayowski; S Iwatsuki; J R Madariaga; R Selby; S Todo; W Irish; T E Starzl
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

8.  Diagnostic dilatation and curettage: is it used appropriately?

Authors:  A Coulter; A Klassen; I Z MacKenzie; K McPherson
Journal:  BMJ       Date:  1993-01-23

9.  Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.

Authors:  William R Jarnagin; Mithat Gonen; Yuman Fong; Ronald P DeMatteo; Leah Ben-Porat; Sarah Little; Carlos Corvera; Sharon Weber; Leslie H Blumgart
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

10.  Laparoscopic management of splenic cysts: marsupialization, cavity lining with surgicel and omentopexy to prevent recurrence.

Authors:  Ryan J McColl; David J Hochman; Clifford Sample
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2007-10       Impact factor: 1.719

View more
  3 in total

1.  Regional variation in the use of surgery in Ontario.

Authors:  Adina E Feinberg; Joan Porter; Refik Saskin; Jagadish Rangrej; David R Urbach
Journal:  CMAJ Open       Date:  2015-07-17

2.  Medial open transversus abdominis plane (MOTAP) catheters for analgesia following open liver resection: study protocol for a randomized controlled trial.

Authors:  Paul Karanicolas; Sean Cleary; Paul McHardy; Stuart McCluskey; Jason Sawyer; Salima Ladak; Calvin Law; Alice Wei; Natalie Coburn; Raynauld Ko; Joel Katz; Alex Kiss; James Khan; Srinivas Coimbatore; Jenny Lam-McCulloch; Hance Clarke
Journal:  Trials       Date:  2014-06-21       Impact factor: 2.279

3.  Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trial.

Authors:  Paul Jack Karanicolas; Yulia Lin; Stuart McCluskey; Rachel Roke; Jordan Tarshis; Kevin E Thorpe; Chad G Ball; Prosanto Chaudhury; Sean P Cleary; Elijah Dixon; Gareth Eeson; Carol-Anne Moulton; Sulaiman Nanji; Geoff Porter; Leyo Ruo; Anton I Skaro; Melanie Tsang; Alice C Wei; Gordon Guyatt
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.